Monday, May 4, 2026
ADVT 
International

Trump plans to sign an order requiring colleges to prove they don't consider race in admissions

Darpan News Desk The Canadian Press, 07 Aug, 2025 10:43 AM
  • Trump plans to sign an order requiring colleges to prove they don't consider race in admissions

President Donald Trump plans to sign an executive order requiring colleges to submit data to prove they do not consider race in admissions, according to a fact sheet shared by the White House ahead of the Thursday signing.


In 2023, the Supreme Court ruled against the use of affirmative action in admissions but said colleges may still consider how race has shaped students’ lives if applicants share that information in their admissions essays. 


Trump's Republican administration is accusing colleges of using personal statements and other proxies to consider race.


The executive order is similar to parts of settlement agreements the administration negotiated with Brown University and Columbia University, restoring their federal research funding. The universities agreed to give the government data on the race, grade point average and standardized test scores of applicants, admitted students and enrolled students.

The schools also agreed to an audit by the government and to release admissions statistics to the public.


Conservatives have argued that despite the Supreme Court ruling, colleges have continued to consider race through proxy measures. But in the first year of admissions after the ruling, no clear pattern emerged in how colleges' diversity changed. Results varied dramatically from one campus to the next.


Some schools, such as the Massachusetts Institute of Technology and Amherst College, saw steep drops in the percentage of Black students in their incoming classes. But at other elite, selective schools such as Yale, Princeton and the University of Virginia, the changes were less than a percentage point year to year. 

Picture Courtesy: AP Photo/Alex Brandon

MORE International ARTICLES

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report